Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NYSE:ARR NASDAQ:SBC On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeARRARMOUR Residential REIT$17.62+0.4%$17.24$13.98▼$19.31$2.18B1.393.03 million shs4.99 million shsSBCSBC Medical Group$3.18-0.9%$3.84$2.97▼$5.75$329.27M0.61166,997 shs67,934 shsAnalysts Agree—These Gold Picks Outshine the RestUnlock the timeless value of gold with our exclusive 2026 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceARRARMOUR Residential REIT0.00%+0.19%+1.35%-0.86%+6.38%SBCSBC Medical Group0.00%-2.73%-26.04%-29.30%+0.31%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeARRARMOUR Residential REIT$17.62+0.4%$17.24$13.98▼$19.31$2.18B1.393.03 million shs4.99 million shsSBCSBC Medical Group$3.18-0.9%$3.84$2.97▼$5.75$329.27M0.61166,997 shs67,934 shsAnalysts Agree—These Gold Picks Outshine the RestUnlock the timeless value of gold with our exclusive 2026 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceARRARMOUR Residential REIT0.00%+0.19%+1.35%-0.86%+6.38%SBCSBC Medical Group0.00%-2.73%-26.04%-29.30%+0.31%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceARRARMOUR Residential REIT 2.20Hold$18.504.98% UpsideSBCSBC Medical Group 2.33Hold$8.50167.30% UpsideCurrent Analyst Ratings BreakdownLatest BRNA, ARR, SBC, and ELTA Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails4/24/2026ARRARMOUR Residential REIT UBS GroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingNeutral$17.50 ➝ $18.004/23/2026ARRARMOUR Residential REIT JonesTradingSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price TargetBuy$20.00 ➝ $19.003/27/2026SBCSBC Medical Group Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (D+)3/20/2026ARRARMOUR Residential REIT Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingDowngradeHold (C-) ➝ Sell (D+)3/20/2026ARRARMOUR Residential REIT Zacks ResearchSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeStrong Sell ➝ Hold3/6/2026ARRARMOUR Residential REIT Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeSell (D+) ➝ Hold (C-)3/6/2026SBCSBC Medical Group BTIG ResearchSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingInitiated CoverageBuy$8.002/20/2026ARRARMOUR Residential REIT JonesTradingSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price TargetBuy$20.50 ➝ $20.002/19/2026ARRARMOUR Residential REIT Zacks ResearchSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingDowngradeHold ➝ Strong Sell(Data available from 5/9/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookARRARMOUR Residential REIT$800.42M2.73$2.68 per share6.58$18.84 per share0.94SBCSBC Medical Group$173.61M1.88$0.52 per share6.14$2.57 per share1.24Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateARRARMOUR Residential REIT$322.69M$1.929.185.87N/A27.43%15.39%1.65%7/22/2026 (Estimated)SBCSBC Medical Group$50.99M$0.496.496.12N/A29.37%20.76%15.67%5/14/2026 (Estimated)Latest BRNA, ARR, SBC, and ELTA EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/14/2026Q1 2026SBCSBC Medical Group$0.10N/AN/AN/A$41.66 millionN/A4/22/2026Q1 2026ARRARMOUR Residential REIT$0.73$0.76+$0.03-$0.49$155.79 million$70.71 million3/27/2026Q4 2025SBCSBC Medical Group$0.13$0.14+$0.01$0.14$45.19 million$39.57 million2/18/2026Q4 2025ARRARMOUR Residential REIT$0.74$0.71-$0.03$1.86$62.34 million$236.50 millionCompare DividendsCompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive GrowthARRARMOUR Residential REIT$2.8816.34%-13.65%150.00%N/ASBCSBC Medical GroupN/AN/AN/AN/AN/ALatest BRNA, ARR, SBC, and ELTA DividendsAnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date4/21/2026ARRARMOUR Residential REITmonthly$0.2416.52%5/15/20265/15/20265/28/20263/25/2026ARRARMOUR Residential REITmonthly$0.2416.4%4/15/20264/15/20264/29/20262/17/2026ARRARMOUR Residential REITmonthly$0.2416.89%3/16/20263/16/20263/30/2026(Data available from 1/1/2013 forward)Compare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioARRARMOUR Residential REITN/A0.020.02SBCSBC Medical Group0.133.783.74Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipARRARMOUR Residential REIT54.17%SBCSBC Medical Group60.82%Insider OwnershipCompanyInsider OwnershipARRARMOUR Residential REIT0.19%SBCSBC Medical Group89.47%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableARRARMOUR Residential REITN/A124.05 million123.81 millionOptionableSBCSBC Medical GroupN/A102.58 million10.80 millionN/ABRNA, ARR, SBC, and ELTA HeadlinesRecent News About These CompaniesSBC Medical Group (NASDAQ:SBC) Upgraded to Hold at Wall Street ZenMay 9 at 2:35 AM | marketbeat.comSBC Medical Group (SBC) to Release Earnings on ThursdayMay 7 at 4:37 AM | marketbeat.comSBC Medical to Announce 1Q 2026 Financial ResultsMay 1, 2026 | globenewswire.comYoshiyuki Aikawa Sells 465,000 Shares of SBC Medical Group (NASDAQ:SBC) StockApril 30, 2026 | insidertrades.comInsider Selling: SBC Medical Group (NASDAQ:SBC) CEO Sells 465,000 Shares of StockApril 29, 2026 | marketbeat.comSBC Medical Group Holdings Incorporated (NASDAQ:SBC) Short Interest UpdateApril 28, 2026 | marketbeat.comSBC Medical Announces Full-Scale Rollout of Aesthetic Healthcare-Focused Interpretation App "Talk Bridge" Across All Shonan Beauty Clinic LocationsApril 27, 2026 | globenewswire.comSBC Medical Group (NASDAQ:SBC) CEO Yoshiyuki Aikawa Sells 3,100,000 SharesApril 24, 2026 | insidertrades.comYoshiyuki Aikawa Sells 3,100,000 Shares of SBC Medical Group (NASDAQ:SBC) StockApril 23, 2026 | marketbeat.comSBC Medical Group Announces CEO Secondary Share OfferingApril 23, 2026 | tipranks.comSBC Medical Group Holdings Incorporated: Emerging Growth Research Releases Flash Report on SBC Medical Group; Reiterates Buy-Extended Rating and $9.00 Price TargetApril 22, 2026 | finanznachrichten.deEmerging Growth Research Releases Flash Report on SBC Medical Group; Reiterates Buy-Extended Rating and $9.00 Price TargetApril 22, 2026 | accessnewswire.comASBC Medical Group stock tumbles on secondary offering pricingApril 21, 2026 | investing.comSBC Medical Group Shares Sink After Pricing Secondary OfferingApril 21, 2026 | marketwatch.comAST SpaceMobile, SBC Medical Group And Other Big Stocks Moving Lower In Monday's Pre-Market SessionApril 21, 2026 | msn.comSBC Medical announces pricing of 3.1M share secondary offering by selling stockholderApril 21, 2026 | msn.comSBC Medical Announces Closing of Previously Announced Secondary Public Offering of 3.1 million shares of Common StockApril 21, 2026 | financialpost.comFSBC Medical Announces Pricing of Secondary Public Offering of 3.1 Million Shares of Common StockApril 19, 2026 | financialpost.comFSBC Medical Announces Pricing of Secondary Public Offering of 3.1 Million Shares of Common StockApril 19, 2026 | businesswire.comSBC Medical Group Holdings Incorporated (NASDAQ:SBC) Sees Significant Drop in Short InterestApril 15, 2026 | marketbeat.comSBC Medical Group Holding Insider Trading Activity | NASDAQ:SBC | BenzingaApril 12, 2026 | benzinga.comNew MarketBeat Followers Over TimeMedia Sentiment Over Time Top HeadlinesView All HeadlinesAmazon: Could Globalstar Be the Missing Spark the Stock Needs?By Sam Quirke | April 9, 2026The $100 Barrel Is Back: Trading The Hormuz Havoc By Jeffrey Neal Johnson | April 15, 2026Intel Went From Market Reject to Musk's AI Partner — What Happens Next?By Sam Quirke | April 13, 2026Is Oracle Undervalued as Cloud Growth Accelerates?By Thomas Hughes | April 29, 2026Follow the Flow: 3 Stocks Absorbing the Market's Biggest RotationBy Bridget Bennett | April 26, 2026BRNA, ARR, SBC, and ELTA Company DescriptionsARMOUR Residential REIT NYSE:ARR$17.62 +0.07 (+0.42%) Closing price 05/8/2026 03:59 PM EasternExtended Trading$17.64 +0.01 (+0.07%) As of 05/8/2026 07:57 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.ARMOUR Residential REIT, Inc. invests in residential mortgage-backed securities (MBS) in the United States. Its securities portfolio primarily consists of the United States Government-sponsored entity's (GSE) and the Government National Mortgage Administration's issued or guaranteed securities backed by fixed rate, hybrid adjustable rate, and adjustable-rate home loans; and unsecured notes and bonds issued by the GSE and the United States treasuries, as well as money market instruments. The company has elected to be taxed as a real estate investment trust. As a result, it would not be subject to corporate income tax on that portion of its net income that is distributed to shareholders. ARMOUR Residential REIT, Inc. was incorporated in 2008 and is based in Vero Beach, Florida.SBC Medical Group NASDAQ:SBC$3.18 -0.03 (-0.93%) Closing price 05/8/2026 04:00 PM EasternExtended Trading$3.19 +0.01 (+0.31%) As of 05/8/2026 07:15 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.SBC Medical Group Holdings Incorporated, through its subsidiaries, provides services to support the operation of clinics which deliver specialized medical services in the areas of cosmetic medicine, esthetic dentistry and Androgenetic Alopecia or AGA, primarily in Japan and centered on the SBC Shonan Beauty Clinic Brand. SBC Medical Group Holdings Incorporated, formerly known as Pono Capital Two Inc., is based in TOKYO. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSilverSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas SoundHound’s Bottom Is In—Inflection and 50% Upside Ahead? Rocket Lab Posts Record Q1 Revenue, Raises Q2 Guidance Hims & Hers Earnings Preview: The Novo Nordisk Shift Puts GLP-1 Strategy in Focus AppLovin Pops After Earnings With Growth Catalysts in Sight Dutch Bros Q1 Earnings: The Newest Starbucks Rival Faces Its First Big Reality Check The AI Fear Around Datadog Stock May Have Been Completely Wrong Amprius Technologies Ups the Voltage on Forward Outlook Why Lam Research Still Looks Like a Buy After a 300% Rally Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
